Raymond James & Associates »

Silverback Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Silverback Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.0012.969352M2.9693525M2.969353M2.9693535M2.969354M204.782k204.7825k204.783k204.7835k204.784k
Value ($)Share countHistorical SPRY position of Raymond James & … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0M 205k 14.50

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Home Depot (HD)
UnitedHealth (UNH)

View all positions for Raymond James & Associates

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics